Musa Tariq - 15 Nov 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Musa Tariq
Issuer symbol
GH
Transactions as of
15 Nov 2025
Net transactions value
$0
Form type
4
Filing time
17 Nov 2025, 17:30:28 UTC
Previous filing
20 Oct 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tariq Musa Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Musa Tariq 17 Nov 2025 0001968281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +250 +3.2% $0.000000 7,975 15 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -250 -5.9% $0.000000 3,998 15 Nov 2025 Common Stock 250 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.